Friedreich's ataxia (FRDA) is a rare, inherited disorder that causes progressive damage to the nervous system. This damage leads to ataxia—problems with movement and coordination—that worsens with ...
Friedreich's Ataxia is caused by deficiency of frataxin, a mitochondrial protein essential for iron–sulfur cluster biogenesis and cellular energy metabolism. Loss of frataxin disrupts mitochondrial ...
Agilis and Intrexon expect DNA-based therapeutics to provide the ability to target underlying disease mechanisms with precision using tightly-controlled gene therapies for patients with rare inherited ...
Agilis Biotherapeutics, LLC and Intrexon Corporation have announced an Exclusive Channel Collaboration (ECC) to develop DNA-based therapeutics for Friedreich’s ataxia (FRDA), a rare genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results